Dew-as a MEDX shareholder, I have considered MEDX's equity position in Genmab as a positive (although not a primary reason to own MEDX). Consequently, I did not like to see MEDX reduce its holdings even though it reduces the need to raise additional cash and dilute the stock. Any comments/opinions.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.